Streetbeat News

Stock Prices

AVGO

Broadcom's (NYSE:AVGO) short interest has decreased by 7.3%, now representing 1.27% of its float with 5.09 million shares sold short. This decline in short interest could indicate a more bullish sentiment towards AVGO among traders. Compared to its peers, Broadcom has a lower short interest percentage of float, suggesting it may be performing better than similar companies.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 8:45 pm

JCI

Johnson Controls Intl's (JCI) short interest has decreased by 23.23%, with 7.24 million shares sold short, representing 1.19% of its float. This decrease in short interest could indicate a more bullish sentiment towards JCI among traders. Compared to its peers, JCI has a lower short interest percentage of float, with an average of 3.74% among its peers, suggesting a relatively positive outlook.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 8:45 pm

VALE

Vale's (NYSE:VALE) short interest has decreased by 11.71%, with 42.52 million shares sold short, representing 0.98% of its float. This decrease in short interest could indicate a more bullish sentiment towards VALE among traders. Compared to its peers, VALE has a significantly lower short interest percentage of float, with an average of 4.66% among its peers, suggesting a stronger position or sentiment in its industry.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 8:45 pm

CXM

Sprinklr's stock price increased following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided optimistic future guidance.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:45 pm

CNQ

COP

DVN

KOS

MGY

XLE

U.S. energy stocks, as indicated by the Energy Select Sector SPDR Fund (XLE), have formed a 'golden cross,' a bullish signal. Goldman Sachs analyst Neil Mehta named ConocoPhillips (COP), Canadian Natural Resources Ltd. (CNQ), Devon Energy Corp. (DVN), Kosmos Energy Ltd. (KOS), and Magnolia Oil & Gas Corp. (MGY) as top upstream oil picks, expecting a 15% average return with Brent at $80 a barrel. Kosmos Energy has the highest potential upside of 26%.

Portfolio Pulse from Piero Cingari

March 27, 2024 | 8:43 pm

JEF

Jefferies Financial Group Inc. (NYSE:JEF) reported Q1 earnings of 87 cents per share, surpassing the analyst consensus of 75 cents, and a 58.18% increase from the previous year. Quarterly sales were $1.74 billion, exceeding estimates by 14.36% and showing a 35.48% year-over-year increase. Investment Banking and Capital Markets net revenues also saw significant increases. CEO Richard Handler highlighted the solid performance across businesses and a strengthening Investment Banking pipeline.

Portfolio Pulse from Erica Kollmann

March 27, 2024 | 8:40 pm

FC

Franklin Covey (NYSE:FC) reported Q2 earnings with a 20.0% beat on estimated EPS, reporting $0.06 versus an estimate of $0.05. However, revenue was down $420 thousand from the same period last year. The company's past earnings performance shows a consistent pattern of beating EPS estimates, which in the last quarter led to a 3.0% increase in share price the following day.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 8:40 pm

PRKS

United Parks & Resorts announced a $500M share repurchase authorization and stockholder approval of an amended stockholders agreement with Hill Path Capital LP. The repurchase program has no set time limit and can be suspended or discontinued at any time.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:37 pm

VRNT

Verint has projected its FY25 earnings per share (EPS) to be around $2.89, slightly above the estimated $2.84. However, its revenue forecast of $930 million, with a possible 2% variance, falls short of the expected $951.8 million.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:36 pm

IPSEY

MACK

Merrimack Pharmaceuticals received a $225 million milestone payment from Ipsen for FDA approval of ONIVYDE for metastatic adenocarcinoma of the pancreas. Merrimack's Board sees no further payments from Ipsen or Elevation Oncology agreements likely and plans a dissolution meeting for May 10, 2024, to discuss a liquidating dividend.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:34 pm